LEVOTHYROXINE SODIUM | A215259 | ASCENT PHARMACEUTICALS INC
Highest NADAC/Unit
$0.1084
per ea
Lowest NADAC/Unit
$0.0362
per ea
Brand NDCs
0
Generic NDCs
24
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722029590LEVOTHYROXINE 300 MCG TABLET | $0.1084 | EA | Generic | — | 2026-06-17 |
| 31722029510LEVOTHYROXINE 300 MCG TABLET | $0.1084 | EA | Generic | — | 2026-06-17 |
| 31722029490LEVOTHYROXINE 200 MCG TABLET | $0.0806 | EA | Generic | — | 2026-06-17 |
| 31722029410LEVOTHYROXINE 200 MCG TABLET | $0.0806 | EA | Generic | — | 2026-06-17 |
| 31722029310LEVOTHYROXINE 175 MCG TABLET | $0.0800 | EA | Generic | — | 2026-06-17 |
| 31722029390LEVOTHYROXINE 175 MCG TABLET | $0.0800 | EA | Generic | — | 2026-06-17 |
Showing 6 of 24 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.